Answers are grounded in this paper and cite their sources.
LUS is a non-invasive, bedside and reproducible method that could improve the management of neonatal respiratory distress. It is accurate and reliable to early identify patients who will need treatment with surfactant allowing both an early treatment and a reduction of radiation exposure.
No takes yet. Share an insight, caveat, or question.
Perri et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: